Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Antimetabolite Drugs Market Overview

Expanding at a CAGR of 1.8%, the global Antimetabolite Drugs market is projected to increase from a valuation of US$ 5,504.3 Mn in 2021 to US$ 6,579.2 Mn by 2032.

“Upsurge in the usage of Antimetabolite Drugss in the cancer therapies and increasing healthcare expenditure will help the global Antimetabolite Drugs market to generate great revenue in the projected period.”

Attributes

Details

Antimetabolite Drugs Market Value in 2021

US$ 5,504.3 Mn

Antimetabolite Drugs Market Value in 2032

US$ 6,579.2 Mn

Antimetabolite Drugs Market CAGR (2022-2032)

1.8%

Drugs that interfere with enzymes and their reactions that are necessary for DNA synthesis are known as antimetabolites. S-Phase is used to build new DNA molecules, antimetabolite interferes and slows the synthesis of pyrimidine and purine which induce the death of cells. Antimetabolites are useful in cancer treatment but are toxic to the normal cell.

Antimetabolites are folic acids and pyrimidine or purine equivalents. These molecules are one of the crucial chemotherapeutic agents and are characterized by low molecular weight molecules. As these compounds have a similar structure to molecules used in nucleic acid synthesis, these molecules are used for different cancer treatments, which include pancreatic cancer, breast cancer, leukaemia, gastro-intestinal cancer, and ovarian cancer.

The existence of Antimetabolite Drugs has a false impact on cell cycles as these drugs inhibit cell division and growth. Therefore, these drugs are commonly used as chemotherapeutics in various cancer cases. Besides cancer therapeutics, Antimetabolite Drugs have different applications such as antibiotics and trabeculectomy.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Factors Responsible for the Growth of the Antimetabolite Drugs Market?

The rapid development in the fields of oncology and drug delivery is expected to show significant growth in the Antimetabolite Drugs market during the forecast period. Additionally, the increased government investments in cancer treatment and diagnosis, research, and initiative to create awareness about cancer are anticipated to drive the global Antimetabolite Drugs market growth.

Moreover, an increase in unhealthy habits such as smoking, and consumption of tobacco are common factors that can cause cancer. This, in turn, is projected to propel the growth of the Antimetabolite Drugs market. Furthermore, an increase in the spending on research and development for cancer research activities in biotechnology and pharmaceutical firms is expected to boost market growth.

Which Region Shows Strong Growth Potential in the Antimetabolite Drugs Market?

Due to well-established research infrastructure and rising interest in research activities, North America dominated the Antimetabolite Drugs market and is expected to show the same growth in the forecast period. Owing to the increasing research on cancer therapeutic and government supported funding policies, Europe has shown high growth in the Antimetabolite Drugs market.

Followed by Europe, East Asia and South Asia is expected to show the rapid growth over the forecast period. This is due to the increased prevalence of cancer and the focus of the government on the development of the medical infrastructure.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who are the Key Manufacturers of the Antimetabolite Drugs Market?

Some of the key players operating in the Antimetabolite Drugs market are Parenteral Drugs Limited., Bristol-Myers Squibb Company, Merck & Co., Inc., Fresenius Kabi Oncology Limited, GlaxoSmithKline plc, Cadila Pharmaceuticals., CELON LABS, Sanofi, Eli Lilly and Company (Lilly), Novartis AG, and Teva Pharmaceutical Industries Ltd.

Scope of the Report

Attributes

Details

Forecast Period

2022-2032

Historical Data Available for

2012-2021

Market Analysis

US$ Mn for Value

By Drug Class

  • Pyrimidine Compounds
  • Purine Compounds
  • Folate Antagonists
  • Demethylation Agents

By Route of Administration

  • Oral
  • Intravenous
  • Intramuscular

By Application

  • Cancer Therapeutic
  • Cardiac Therapeutic
  • Arthritis Therapeutic

By Distribution Channel

  • Retail Sales
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Players

  • Parenteral Drugs Limited.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Fresenius Kabi Oncology Limited
  • GlaxoSmithKline plc
  • Cadila Pharmaceuticals
  • CELON LABS
  • Sanofi SA
  • Eli Lilly and Company (Lilly)
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Covered in the Antimetabolite Drug Industry Survey

By Drug Class:

  • Pyrimidine Compounds
  • Purine Compounds
  • Folate Antagonists
  • Demethylation Agents

By Route of Administration:

  • Oral
  • Intravenous
  • Intramuscular

By Application:

  • Cancer Therapeutic
  • Cardiac Therapeutic
  • Arthritis Therapeutic

By Distribution Channel:

  • Retail Sales
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

What is the Growth Outlook for The Global Antimetabolite Drugs Market?

The global Antimetabolite Drugs market is anticipated to register a CAGR of 1.8% during the forecast period.

Who Are the Top 3 Players in The Global Antimetabolite Drugs Market?

The top 3 players in the global Antimetabolite Drugs market are Parenteral Drugs Limited., Bristol-Myers Squibb Company, and Merck & Co.

Explore Healthcare Insights

View Reports

Antimetabolite Drugs Market

Schedule a Call